Incannex Healthcare begins Phase 2 rheumatoid arthritis trial
MELBOURNE: Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) has kicked off a Phase 2 clinical ...
To read the full story...SUBSCRIBE NOWExisting Subscribers Login Below:
Log In
